HSP90AB1 and pancreatic neoplasm: High expression levels of HSP90AA1 and HSP90AB1 (associated with a low MZF1 expression scenario) were significantly correlated with poorer prognosis of patients suffering from pancreatic cancer (Figure 8D–F).